BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3923026)

  • 21. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
    Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
    J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly.
    Losa M; Oeckler R; Schopohl J; Müller OA; Alba-Lopez J; von Werder K
    J Neurosurg; 1989 Apr; 70(4):561-7. PubMed ID: 2647918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth hormone and prolactin responses to bolus and sustained infusions of GRH-1-40-OH in man.
    Goldman JA; Molitch ME; Thorner MO; Vale W; Rivier J; Reichlin S
    J Endocrinol Invest; 1987 Aug; 10(4):397-406. PubMed ID: 3119697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of growth hormone and prolactin secretion by luteinizing hormone-releasing hormone and its blockade by bromoergocriptine in acromegalic patients.
    Ishibashi M; Yamaji T; Kosaka K
    J Clin Endocrinol Metab; 1978 Aug; 47(2):418-21. PubMed ID: 400720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [GH and PRL after TRH and hpGRF(1-40) administration in 2 cases of acromegaly with hyperprolactinemia].
    Sampaolo G; Faloia E; Sarzani R; Bartolacci V; Schiavo P; Butini L; Morosini P
    Recenti Prog Med; 1987 Mar; 78(3):115-8. PubMed ID: 3110882
    [No Abstract]   [Full Text] [Related]  

  • 28. Acromegaly: biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy.
    Serri O; Somma M; Comtois R; Rasio E; Beauregard H; Jilwan N; Hardy J
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1185-9. PubMed ID: 4055986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
    De Leo V; Petraglia F; Sardelli S; Danero S; Genazzani AR; D'Antona N
    Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid metabolism in acromegalic patients before and after selective pituitary adenomectomy.
    Tsuchiya H; Onishi T; Mogami H; Iida M
    Endocrinol Jpn; 1990 Dec; 37(6):797-807. PubMed ID: 2129301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pooled prolactin measurements in the evaluation of short children.
    Shulman DI; Hu CS; Root AW; Bercu BB
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1261-7. PubMed ID: 2511222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].
    De Marinis L; Mancini A; Zuppi P; Fiumara C; Iacona T; Conte G; Fabrizi ML; Valle D; Anile C; Maira G
    Minerva Chir; 1993 Nov; 48(21-22):1337-40. PubMed ID: 8152567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the serum hormone levels and histological findings in pituitary adenomas.
    Irsy G; Góth M; Bálint K; Slowik F; Szabolcs I; Pásztor E; Szilágyi G
    Exp Clin Endocrinol; 1986 Dec; 88(2):224-36. PubMed ID: 3104069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
    Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolactin secreting tumors. Endocrine status before and after surgery in 33 women.
    Jaquet P; Grisoli F; Guibout M; Lissitzky JC; Carayon P
    J Clin Endocrinol Metab; 1978 Mar; 46(3):459-66. PubMed ID: 109458
    [No Abstract]   [Full Text] [Related]  

  • 36. Prolactin and luteinizing hormone profiles of cured acromegalic subjects.
    Roelfsema F; Frölich M; de Boer H
    Clin Endocrinol (Oxf); 1989 Oct; 31(4):439-51. PubMed ID: 2516783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for the release of a novel pituitary polypeptide (7B2) from the growth hormone-producing pituitary adenoma of patients with acromegaly.
    Natori S; Iguchi H; Nawata H; Kato K; Ibayashi H; Nakagaki H; Chrétien M
    J Clin Endocrinol Metab; 1988 Feb; 66(2):430-7. PubMed ID: 3123513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin.
    De Marinis L; Zuppi P; Valle D; Mancini A; Bianchi A; Lauriola L; Pasquini P; Anile C; Maira G; Giustina A
    Horm Metab Res; 2002 Mar; 34(3):137-43. PubMed ID: 11972303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolactin dynamics and tumour size in the prediction of surgical outcome for prolactinoma.
    Gordon D; Richards A; Bulloch R; Cohen HN; Semple CG; Beastall GH; Thomson JA; Teasdale G
    Q J Med; 1985 Feb; 54(214):141-51. PubMed ID: 3920723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.